Wave Life Sciences (WVE) Depreciation & Amortization (CF) (2014 - 2026)
Wave Life Sciences (WVE) posted Depreciation & Amortization (CF) of $841000.0 for Q1 2026, little changed on a QoQ basis from $844000.0 in Q4 2025, and down 3.89% year-over-year from $875000.0 in Q1 2025.
Wave Life Sciences (WVE) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Wave Life Sciences' Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $841000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 3.89% year-over-year to $841000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 8.66% YoY) and the FY2025 annual result came in at $3.4 million, down 11.7% from the prior year.
- Depreciation & Amortization (CF) was $841000.0 for Q1 2026 at Wave Life Sciences, roughly flat from $844000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.7 million in Q1 2022 and bottomed at $841000.0 in Q1 2026.
- A 5-year average of $1.2 million and a median of $1.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) decreased 28.51% — and 2026, when it dropped 3.89%.
- Wave Life Sciences' Depreciation & Amortization (CF) stood at $1.5 million in 2022, then dropped by 28.51% to $1.1 million in 2023, then decreased by 16.1% to $907000.0 in 2024, then retreated by 6.95% to $844000.0 in 2025, then decreased by 0.36% to $841000.0 in 2026.
- Business Quant data shows WVE's Depreciation & Amortization (CF) at $841000.0 in Q1 2026, $844000.0 in Q4 2025, and $856000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 841,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 841,000.00 |
| Mar 31, 2026 | 841,000.00 |
| Dec 31, 2025 | 844,000.00 |
| Dec 31, 2025 | 844,000.00 |
| Sep 30, 2025 | 856,000.00 |
| Sep 30, 2025 | 856,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Mar 31, 2025 | 875,000.00 |
| Mar 31, 2025 | 875,000.00 |
| Dec 31, 2024 | 907,000.00 |
| Dec 31, 2024 | 907,000.00 |
| Sep 30, 2024 | 948,000.00 |
| Sep 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 999,000.00 |
| Jun 30, 2024 | 999,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Dec 31, 2023 | 1.08 Mn |